Abstract
Despite the HPV vaccine’s efficacy in preventing cervical cancer, its coverage rates among Asians are very low. To increase immunization coverage among these populations, understanding the psychological factors that affect HPV acceptability is critical. To this end, this study examined the relationships between multidimensional health beliefs and HPV vaccine acceptance, and what information sources effectively foster HPV vaccination-related health beliefs. Data were collected using a survey of 323 undergraduate students in Korea. Results showed that perceived susceptibility, perceived severity, perceived benefits, and perceived vaccine safety concerns predicted vaccine acceptance. Multiple dimensions of perceived barriers showed differing impacts on vaccine acceptance. In addition, interpersonal information sources were effective in boosting various health beliefs for HPV vaccination. The Internet also was effective in reducing social barriers, but the effects were opposite to those of social media. Theoretical and practical implications are discussed.
Highlights
In 2012, approximately 528,000 new cervical cancer cases were found, and 266,000 women lost their lives, ranking cervical cancer as women’s fourth most common cancer worldwide [1].The human papillomavirus (HPV) vaccines (e.g., Gardasil® and Cervarix® ) have been found to reduceHPV-related diseases, including cervical cancer or genital warts, and are recommended for both males and females [2,3]
Cervical cancer ranks second in causing morbidity and mortality for Asian women, implying that many of these deaths are preventable with the HPV vaccine [4]
This study aimed to explore how health beliefs affect vaccination-related attitudes and intentions as well as what information sources are effective in boosting health beliefs regarding HPV vaccination
Summary
In 2012, approximately 528,000 new cervical cancer cases were found, and 266,000 women lost their lives, ranking cervical cancer as women’s fourth most common cancer worldwide [1].The human papillomavirus (HPV) vaccines (e.g., Gardasil® and Cervarix® ) have been found to reduceHPV-related diseases, including cervical cancer or genital warts, and are recommended for both males and females [2,3]. In 2012, approximately 528,000 new cervical cancer cases were found, and 266,000 women lost their lives, ranking cervical cancer as women’s fourth most common cancer worldwide [1]. The human papillomavirus (HPV) vaccines (e.g., Gardasil® and Cervarix® ) have been found to reduce. HPV-related diseases, including cervical cancer or genital warts, and are recommended for both males and females [2,3]. Cervical cancer ranks second in causing morbidity and mortality for Asian women, implying that many of these deaths are preventable with the HPV vaccine [4]. The estimated HPV vaccination coverage rates in that region are very low. The full coverage rates among the females in their 10–20 years was 35.6% in North America, 31.1% in Europe, and 35.9% in Oceania, but remained
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Environmental Research and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
